ATRX — Adhera Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $0.06m
- $8.45m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 3.92 | 0.05 | 0.001 | 0.076 | 0.032 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.048 | 0 | — | — | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 4.68 | 0.42 | 0.001 | 0.196 | 0.079 |
Net Property, Plant And Equipment | 0.072 | 0 | — | — | — |
Net Goodwill | |||||
Net Intangible Assets | |||||
Total Assets | 5.14 | 0.42 | 0.001 | 0.196 | 0.079 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.21 | 10.3 | 14.8 | 25.3 | 22.3 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 2.21 | 10.3 | 14.8 | 25.3 | 22.3 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Total Equity | 2.93 | -9.89 | -14.8 | -25.1 | -22.2 |
Total Liabilities & Shareholders' Equity | 5.14 | 0.42 | 0.001 | 0.196 | 0.079 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |